H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

Gut

Volumn 60, Issue 4, 2011, Pages 456-462

  Rahier, Jean François ^a   Papay, Pavol ^b   Salleron, Julia ^c   Sebastian, Shaji ^d   Marzo, Manuela ^e   Peyrin Biroulet, Laurent ^f   Garcia Sanchez, Valle ^g   Fries, Walter ^h   Van Asseldonk, Dirk P ⁱ   Farkas, Klaudia ^j   De Boer, Nanne K ^k   Sipponen, Taina ^l   Ellul, Pierre ^m   Louis, Edouard ⁿ   Peake, Simon T C ^o   Kopylov, Uri ^p   Maul, Jochen ^q   Makhoul, Badira ^r   Fiorino, Gionata ^s   Yazdanpanah, Yazdan ^t   Chaparro, Maria ^u   more..

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIV LILLE   (France)

^d HULL ROYAL INFIRMARY   (United Kingdom)

^e CATHOLIC UNIVERSITY   (Italy)

^f UNIVERSITÉ DE LORRAINE   (France)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF SZEGED   (Hungary)

^k Infection and Immunology   (Netherlands)

^l HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^m MATER DEI HOSPITAL   (Malta)

ⁿ UNIVERSITY OF LIÈGE   (Belgium)

^o ST MARK S HOSPITAL   (United Kingdom)

^p SHEBA MEDICAL CENTER   (Israel)

^q CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^r H Reina Sofia   (Spain)

^s HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^t INSERM   (France)

^u INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CALCINEURIN INHIBITOR; CERTOLIZUMAB PEGOL; CORTICOSTEROID; FLUVALP; IMMUNOMODULATING AGENT; INFLIXIMAB; INFLUENZA VACCINE; MERCAPTOPURINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ADULT; ARTHRALGIA; ARTICLE; BIOLOGICAL THERAPY; BLOODY DIARRHEA; COHORT ANALYSIS; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; ENTERITIS; EUROPE; FATIGUE; FEMALE; HARVEY BRADSHAW INDEX; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; INJECTION SITE WARMTH; INTESTINE MOTILITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; OBSERVATIONAL STUDY; PARTIAL MAYO SCORE; PRIORITY JOURNAL; SCORING SYSTEM; SHIVERING; SIDE EFFECT; ULCERATIVE COLITIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC FACTORS; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 79952538494     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.233981     Document Type: Article

References (27)

1. Ginsberg M, Hopkins J, Maroufi A, et al. Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-2.
2. Clark TW, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009;361:2424-35.
3. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009;361:2405-13.
4. Rahier JF, Yazdanpanah Y, Viget N, et al. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2010;31:5-10.
5. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
6. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-9. (Pubitemid 18010466)
7. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5-36.
8. Best WR. Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index. Inflamm Bowel Dis 2006;12:304-10.
9. Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008;14:1660-6.
10. Vermeire S, Schreiber S, Sandborn WJ, et al. Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. Clin Gastroenterol Hepatol 2010;8:357-63.
11. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76. (Pubitemid 41770166)
12. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 1992;11:2093-109. (Pubitemid 23066842)
13. Vajo Z, Tamas F, Sinka L, et al. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010;375:49-55.
14. Treanor JJ, Campbell JD, Zangwill KM, et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006;354:1343-51.
15. Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine 2001;19:2673-80. (Pubitemid 32234288)
16. De Donato S, Granoff D, Minutello M, et al. Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine 1999;17:3094-101. (Pubitemid 29366990)
17. Gasparini R, Pozzi T, Montomoli E, et al. Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. Eur J Epidemiol 2001;17:135-40. (Pubitemid 32900039)
18. http://www.ema.europa.eu/ema/index (accessed 21 Nov 2010).
19. Pellegrini M, Nicolay U, Lindert K, et al. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine 2009;27:6959-65.
20. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008;8:124-8.
21. Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E, et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 2007;66:1384-7. (Pubitemid 47492487)
22. Borte S, Liebert UG, Borte M, et al. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford) 2009;48:144-8.
23. Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010;49:1815-27.
24. Del Porto F, Lagana B, Biselli R, et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006;24:3217-23.
25. Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 2006;65:191-4. (Pubitemid 43131992)
26. Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009;104:444-53.
27. Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:851-6. (Pubitemid 47031059)